AI assistant
GENETIC TECHNOLOGIES LIMITED — Board/Management Information 2021
Aug 2, 2021
65022_rns_2021-08-02_e34e155c-c5d8-43b1-bd45-9c5ba3f1c263.pdf
Board/Management Information
Open in viewerOpens in your device viewer
ASX Market Announcement
==> picture [110 x 70] intentionally omitted <==
Change in Company Secretary
Melbourne, Australia, 3 August 2021: Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in Genomics tests in health, wellness and serious disease advises that in accordance with ASX Listing Rule 3.16.1, Justyn Stedwell has resigned from the role of Company Secretary with immediate effect. The Board acknowledges and thanks Justyn for his service and contribution to the Company over the last few years.
GTG advises that Chief Financial Officer, Michael Tonroe, has been appointed as Company Secretary with effect from 2 August 2021. For the purposes of ASX listing rule 12.6, GTG wishes to confirm that Michael Tonroe is the person responsible for communications between the Company and ASX. The changes are effective immediately.
-END-
Genetic Technologies Limited 60-66 Hanover Street www.gtglabs.com Fitzroy Victoria 3065 [email protected] Australia ABN 17 009 212 328 +61 3 8412 7000
==> picture [78 x 49] intentionally omitted <==
Investor Relations (AUS) Investor Relations and Media (US) Stephanie Ottens Dave Gentry Market Eye 1 800 RED CHIP (733 2447) M: +61 434 405 400 Cell: 407 491 4498 E: [email protected] E: [email protected]
About Genetic Technologies Limited
Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) is a diversified molecular diagnostics company. GTG offers cancer predictive testing and assessment tools to help physicians proactively manage patient health. The Company’s lead products GeneType for Breast Cancer for non-hereditary breast cancer and GeneType for Colorectal Cancer are clinically validated risk assessment tests and are first in class. Genetic Technologies is developing a pipeline of risk assessment products.
For more information, please visit www.gtglabs.com
Genetic Technologies Limited 60-66 Hanover Street www.gtglabs.com Fitzroy Victoria 3065 [email protected] Australia ABN 17 009 212 328 +61 3 8412 7000